BIOCON vs GLAND — stock comparison
Biocon Ltd (BIOCON) vs Gland Pharma Ltd (GLAND): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, GLAND grades higher (C 58 vs A 83). Not investment advice.
1-year price performance — higher line = stronger return
■ BIOCON +6.3%■ GLAND +56.2%Past year, both rebased to 100
| BIOCON | GLAND | |
|---|---|---|
| Traddx grade | C (58) | A (83) |
| Price | ₹368.60 | ₹3,006.90 |
| Today | -0.31% | 3.22% |
| P/E | 82.70 | 43.30 |
| ROE | 1.40% | 10.70% |
| Net margin | 8.36% | 28.32% |
| Debt / equity | 0.45 | 0.03 |
| 52-week high | ₹447.00 | ₹3,041.95 |
| 52-week low | ₹337.95 | ₹1,575.00 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open BIOCON live → Open GLAND live →